© 2015 by Arnold Strategies, LLC.

CONNECT:

  • LinkedIn Classic
Previous Positions:
First Light Biosciences: Investor, Director and Chairman
First Light is developing a system that can rapidly diagnose hospital acquired infections and determine antibiotic resistance and susceptibility of identified pathogens.

Coravin: Investor, Co-founder and Director

Coravin allows the user to remove any amount of wine from a bottle without removing the cork. The remaining wine ages as if untouched. See http://www.coravin.com/

 

Corbus Pharmaceuticals: Investor, Director and Chairman

Corbus (formerly known as JB Therapeutics) has a drug for cystic fibrosis, scleroderma and other orphan fibrotic diseases in phase 2 and 3 trials. Corbus became a public company in December '14.

 

CardioFocus, Inc., Chairman and CEO

CardioFocus has a laser catheter ablation system for the treatment of atrial fibrillation marketed in the EU and US. 

 

Cambridge Heart, Inc.: Founder and CEO

Raised the first financing for this supplier of cardiology diagnostic equipment, built the team, developed the product, obtained approvals / reimbursement and marketed the product worldwide. Goldman Sachs led IPO in 1996.

 

Molecular Simulations / Accelyrs: CEO

A $300 million supplier of software tools for rational drug design. Previously public it was sold to Dassault Systemes in April 2014.

 

Arnold & Associates

As an interrim CEO, completed three successful turnarounds for investors.

 

Skantek: EVP then CEO

Skantek allowed utilities to scan and edit large format map data. Sold to Xerox.

 

Datascope Corp, VP Operations & GM Instrumentation

Now a $500 MM division of Maquet. Ran the instrumentation group responsible for 75% of company revenues and grew it by 3x in 4 years.

 

Becton Dickinson, Medical Systems

At different times ran engineering, marketing and distribution for this B-D division selling instrumentation and systems to hospitals and clinical labs.  Trained in strategy, became part of a corporate wide strategy leadership team.

 

MIT: BSEE ('72)
Current Positions:
Arnold Strategies, LLC

Strategic advisor to early and growth stage CEO's. Help talented CEO's with strategy, financing, marketing, team building and strategic partnerships.

 

Angel Investor with Boston Harbor Angels, Mass Med Angels and Sky Ventures
Invested in Smart Cells (sold to Merck), Syntonix (sold to Biogen Idec), Health Honors (sold to Healthways), BioAssets (sold to Cephalon), Intelligent BioSystems (sold to Qiagen), Spryance (sold to Heartland), JB Therapeutics (now public as Corbus Pharma), Myomo (now public) and others.

Astrocyte Pharmaceuticals, Inc.: Investor and Director

Astrocyte is developing a drug to reduce the loss of brain function caused by acute stroke and traumatic brain injury.

Museum of Science: Board of Overseers 

This wonderful institution ingnites a passion for science and technology in young people throughout our region and Country.

Mentor: MIT Venture Mentoring, Desphande Center, Mass Challenge

Giving back to young entrepreneurs from MIT and elsewhere.